Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02359 WUXI APPTEC
RTNominal up37.100 +0.250 (+0.678%)
Others

06/11/2019 17:07

Moody's assigns first-time "Baa3" to WuXi AppTec (02359)

[ET Net News Agency, 6 November 2019] Moody's Investors Service has assigned a
first-time Baa3 issuer rating to WuXi AppTec Co Ltd. The outlook is stable.
"WuXi AppTec's Baa3 issuer rating reflects its leading market position as a contract
research organization with a full-service pharmaceutical research and development (R&D)
services platform, its global operations, its solid credit metrics, and the strong growth
prospects for the sector in China," said Shawn Xiong, a Moody's Assistant Vice President
and Analyst.
WuXi AppTec is a leading contract research organization (CRO) with a full-service
pharmaceutical R&D services platform with global operations. The company's research and
manufacturing services cover the full spectrum of discovery, development and manufacturing
of small molecule drugs, cell and gene therapies. It also provides testing services for
medical devices.
WuXi AppTec's reported revenue grew around 23.8% to around RMB9.6 billion for 2018. Such
strong revenue growth combined with the company's cost competitiveness has translated into
strong operating cash flow generation, with its adjusted EBITDA margin ranging between 30%
and 33% over the three years to 2018. (KL)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.